Each tablet contains Azithromycin Dihydrate USP equivalent to Anhydrous Azithromycin 500 mg.
Azipac is an azalide. A subclass of macrolide antibiotics, for oral administration. Azipac is rapidly absorbed and widely distributed throughout the body. Rapid distribution of Azipac into tissues and high concentration within cells result in significantly higher concentrations in tissues such as tonsil, lung and prostate, than in plasma or serum.
Azipac is active against most strains of the following Gram Positive and Gram Negative organisms: Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae; Haemophilus influenzae and parainfluenzae, Moraxella catarrhalis, Bacteroides fragilis; Escherichia coli, Bordetella pertussis, Bordetella parapertussis, Borrelia burgdorferi, Haemophilus ducreyi, Neisseria gonorrhoeae and Chlamydia trachomatis. Azipac also demonstrates in vitro activity against Legionella pneumophila, Mycoplasma pneumoniae and hominis, Campylobacter, Toxoplasma gondii, Treponema pallidum, Ureaplasma urealyticum.
Azipac is indicated for the treatment of: Upper respiratory tract infections including Pharyngitis, Tonsillitis, Sinusitis.
Lower respiratory tract infections including bronchitis and pneumonia.
Sexually transmitted diseases including non-gonococcal urethritis and cervicitis.
Otitis media.
Skin and skin structure infection.
For adults. (See table.)
Click on icon to see table/diagram/image
There is no data on overdose with Azithromycin. Gastric lavage and general supportive measures are indicated.
Azithromycin is contraindicated in patients with a known hypersensitivity to it or any of the macrolide antibiotics.
Because of the theoretical possibility of ergotism, Azithromycin should not be administered concomitantly with ergot derivatives. The use of broad spectrum antibiotics may lead to overgrowth of non-susceptible organisms.
Azithromycin should be used with caution in patients with impaired hepatic function. No adjustment in dose is required in patients with mild renal impairment (creatinine clearance 40 ml/min), but there is no data regarding the use of Azithromycin in patients with more severe renal function impairment. Azithromycin is rated FDA pregnancy category B. It is not known whether Azithromycin is distributed into human breast milk or not, therefore caution should be exercised when Azithromycin is administered to nursing mother.
Azithromycin is well tolerated with a low incidence of side effects. The majority of side effects were gastrointestinal in origin such as nausea, vomiting, diarrhea and flatulence. Other side effects include rashes and reversible elevations in liver transaminases.
Store in a cool, dry place below 30°C. Protect from light & moisture.
J01FA10 - azithromycin ; Belongs to the class of macrolides. Used in the systemic treatment of infections.
Sign Out
